ODonnell M, Mente A, Rangarajan S, McQueen MJ, Wang X, Liu L, et al
The lot-specific Certificate of Analysis documents the lot number, both compound purities, the blend ratio, and the full methodology
A 2025 meta-analysis pooling three trials (878 participants) confirmed the pattern: significantly greater weight loss than placebo about ~14% of total body weight on average with no significant rise in overall adverse events [6] [7]
Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease, said Ania Jastreboff, MD, PhD, Lead Investigator and Director of the Yale Obesity Research Center
Healthcare providers considering this combination should implement enhanced monitoring protocols and maintain heightened vigilance for adverse effects
Forman HJ1, Zhang H, Rinna A